SCHEMBL220596

SCHEMBL220596

COc1cc(Nc2cc(C(F)(F)F)nc(N[C@@H](C)c3ncc(F)cn3)n2)n[nH]1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
JAK3 P52333 12/20 0.49
JAK2 O60674 16/20 0.48
AURKA O14965 3/20 0.46
NTRK1 P04629 3/20 0.46
AURKB Q96GD4 2/20 0.46
PLK4 O00444 1/20 0.46
STK10 O94804 1/20 0.46
PAK4 O96013 1/20 0.46
RET P07949 1/20 0.46
FGFR1 P11362 1/20 0.46
FER P16591 1/20 0.46
CSNK2A2 P19784 1/20 0.46
JAK1 P23458 1/20 0.46
TYK2 P29597 1/20 0.46
FLT3 P36888 1/20 0.46
STAT3 P40763 1/20 0.46
STAT5A P42229 1/20 0.46
CDK3 Q00526 1/20 0.46
PTK2 Q05397 1/20 0.46
TNK2 Q07912 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL220676 0.86 JAK2 (0.55) JAK3JAK2AURKANTRK1AURKB
SCHEMBL218403 0.79 JAK2 (0.59) JAK3JAK2AURKANTRK1AURKB
SCHEMBL220721 0.79 JAK3 (0.79) JAK3JAK2AURKANTRK1AURKB
SCHEMBL220720 0.77 JAK2 (0.76) JAK3JAK2AURKANTRK1AURKB
SCHEMBL220217 0.77 JAK2 (0.76) JAK3JAK2AURKANTRK1AURKB
SCHEMBL220606 0.76 JAK2 (0.55) JAK3JAK2AURKANTRK1AURKB
SCHEMBL3950465 0.74 NTRK1 (0.53) JAK3JAK2AURKANTRK1AURKB
SCHEMBL218817 0.73 JAK2 (0.73) JAK3JAK2
SCHEMBL13904391 0.72 JAK2 (0.50) JAK3JAK2AURKANTRK1AURKB
SCHEMBL220649 0.72 JAK2 (0.53) JAK3JAK2AURKANTRK1AURKB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8088784-B2 4-(3-aminopyrazole) pyrimidine derivatives for use as tyrosine kinase inhibitors in the treatment of cancer ASTRAZENECA AB (SE) 2012-01-03 US disclosed